Total Payments
$142,340
2022 Payments
$6,065
Companies
2
Transactions
77
Medicare Patients
5,528
Medicare Billing
$316,928
Payment Breakdown by Category
Consulting$142,340 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $142,340 | 77 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $127,485 | 44 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $14,855 | 33 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $6,065 | 3 | PFIZER INC. ($6,065) |
| 2021 | $21,265 | 15 | PFIZER INC. ($21,115) |
| 2020 | $45,935 | 15 | PFIZER INC. ($45,615) |
| 2019 | $47,805 | 17 | PFIZER INC. ($46,360) |
| 2018 | $15,985 | 17 | PFIZER INC. ($8,330) |
| 2017 | $5,285 | 10 | Merck Sharp & Dohme Corporation ($5,285) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/25/2022 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $340.00 | General |
| Category: ONCOLOGY | ||||||
| 03/31/2022 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,005.00 | General |
| Category: ONCOLOGY | ||||||
| 02/17/2022 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $4,720.00 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $2,615.00 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $2,015.00 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $3,835.00 | General |
| Category: ONCOLOGY | ||||||
| 09/15/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $195.00 | General |
| Category: ONCOLOGY | ||||||
| 09/15/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $60.00 | General |
| Category: ONCOLOGY | ||||||
| 08/18/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,560.00 | General |
| Category: ONCOLOGY | ||||||
| 07/14/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,690.00 | General |
| Category: ONCOLOGY | ||||||
| 06/10/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $910.00 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,795.00 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: ONCOLOGY | ||||||
| 04/15/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $585.00 | General |
| Category: ONCOLOGY | ||||||
| 03/18/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,690.00 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,365.00 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2021 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $2,860.00 | General |
| Category: ONCOLOGY | ||||||
| 01/28/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $50.00 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $5,155.00 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $20.00 | General |
| Category: ONCOLOGY | ||||||
| 09/14/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $10,530.00 | General |
| Category: ONCOLOGY | ||||||
| 09/14/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $80.00 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $715.00 | General |
| Category: ONCOLOGY | ||||||
| 07/20/2020 | PFIZER INC. | LORBRENA (Drug) | Consulting Fee | Cash or cash equivalent | $3,610.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,372 | 8,115 | $525,285 | $74,897 |
| 2022 | 26 | 1,373 | 11,087 | $595,163 | $81,049 |
| 2021 | 28 | 1,511 | 8,248 | $543,021 | $83,980 |
| 2020 | 26 | 1,272 | 9,139 | $508,843 | $77,002 |
Total Patients
5,528
Total Services
36,589
Medicare Billing
$316,928
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 70553 | Mri scan of brain before and after contrast | Facility | 2023 | 131 | 131 | $75,718 | $11,626 | 15.4% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 266 | 275 | $46,618 | $8,750 | 18.8% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 29 | 29 | $110,425 | $8,029 | 7.3% |
| 70496 | Ct scan of blood vessels of head with contrast | Facility | 2023 | 79 | 81 | $28,075 | $5,472 | 19.5% |
| 70498 | Ct scan of blood vessels of neck with contrast | Facility | 2023 | 77 | 79 | $27,370 | $5,153 | 18.8% |
| 70491 | Ct scan of soft tissue of neck with contrast | Facility | 2023 | 98 | 98 | $26,957 | $5,066 | 18.8% |
| 70551 | Mri scan of brain without contrast | Facility | 2023 | 87 | 87 | $32,712 | $4,672 | 14.3% |
| 76536 | Ultrasound scan of head and neck soft tissue | Facility | 2023 | 171 | 178 | $20,292 | $3,800 | 18.7% |
| 70543 | Mri scan of bone of eye socket, face, and/or neck before and after contrast | Facility | 2023 | 43 | 44 | $23,804 | $3,605 | 15.1% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 53 | 53 | $12,701 | $2,214 | 17.4% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 12 | 12 | $22,658 | $2,070 | 9.1% |
| 70492 | Ct scan of soft tissue of neck before and after contrast | Facility | 2023 | 27 | 27 | $8,892 | $1,764 | 19.8% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Facility | 2023 | 29 | 29 | $9,622 | $1,736 | 18.0% |
| 70491 | Ct scan of soft tissue of neck with contrast | Office | 2023 | 13 | 14 | $15,427 | $1,728 | 11.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 56 | 56 | $13,104 | $1,591 | 12.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 34 | 34 | $11,910 | $1,255 | 10.5% |
| 72158 | Mri scan of lower spinal canal before and after contrast | Facility | 2023 | 13 | 13 | $7,295 | $1,163 | 15.9% |
| 70480 | Ct scan of cranial cavity without contrast | Facility | 2023 | 23 | 23 | $5,860 | $1,162 | 19.8% |
| 70544 | Mri scan of blood vessels of head without contrast | Facility | 2023 | 25 | 25 | $5,977 | $1,124 | 18.8% |
| 72148 | Mri scan of lower spinal canal without contrast | Facility | 2023 | 16 | 16 | $5,836 | $941.33 | 16.1% |
| 70486 | Ct scan of face without contrast | Facility | 2023 | 19 | 19 | $4,009 | $612.69 | 15.3% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2023 | 33 | 5,000 | $5,000 | $574.99 | 11.5% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 18 | 18 | $3,249 | $572.07 | 17.6% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 20 | 1,774 | $1,774 | $215.55 | 12.2% |
| 70553 | Mri scan of brain before and after contrast | Office | 2022 | 46 | 47 | $167,732 | $12,173 | 7.3% |
About Dr. Hillary Kelly, MD
Dr. Hillary Kelly, MD is a Diagnostic Radiology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013044452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hillary Kelly, MD has received a total of $142,340 in payments from pharmaceutical and medical device companies, with $6,065 received in 2022. These payments were reported across 77 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($142,340).
As a Medicare-enrolled provider, Kelly has provided services to 5,528 Medicare beneficiaries, totaling 36,589 services with total Medicare billing of $316,928. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Boston, MA
- Active Since 02/27/2007
- Last Updated 07/26/2012
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1013044452
Products in Payments
- LORBRENA (Drug) $127,160
- KEYTRUDA (Biological) $14,855
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Boston
Andrew Kompel, M.d, M.D
Diagnostic Radiology — Payments: $3.4M
Diagnostic Radiology $3.4M
Gregg Miller, M.d, M.D
Diagnostic Radiology — Payments: $3.0M
Diagnostic Radiology $3.0M
Stephan Anderson, M.d, M.D
Diagnostic Radiology — Payments: $2.4M
Diagnostic Radiology $2.4M
Ashraf Thabet, M.d, M.D
Diagnostic Radiology — Payments: $1.7M
Diagnostic Radiology $1.7M
Dr. Mukesh Harisinghani, Md, MD
Diagnostic Radiology — Payments: $1.4M
Diagnostic Radiology $1.4M
Subba Digumarthy, Md, MD
Diagnostic Radiology — Payments: $1.1M
Diagnostic Radiology $1.1M